Keratoconus patients have better opportunities than ever for treatments of their condition. Two new technologies have now been combined to offer a substantial benefit for patients with keratoconus. Corneal Collagen Crosslinking with Riboflavin combined with Intacs treatment offers an opportunity to possibly stop the deterioration of the cornea and even reverse it in many cases.
In the past, patients with keratoconus would wear hard contact lenses until those no longer helped. At that point, they would have a corneal transplant. Studies suggest however that early treatment may be beneficial in preventing this decline. Rather than wearing contact lenses until they fail, it is believed that intacs corneal inserts can be an earlier solution. Riboflavin treatment can also be used to improve the strength of the cornea.